Sec Form 4 Filing - GAUSLING MICHAEL J @ Tabula Rasa HealthCare, Inc. - 2016-10-04

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person GAUSLING MICHAEL J 2. Issuer Name and Ticker or Trading Symbol Tabula Rasa HealthCare, Inc. [ TRHC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 205 WEBSTER STREET 3. Date of Earliest Transaction (MM/DD/YY) 10/04/2016 (Street) BETHLEHEM, PA18015 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/04/2016 C 1,516,070 A 1,636,888 I By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P. ( 3 ) Common Stock 10/04/2016 C 971,012 A 2,607,900 I By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P. ( 3 ) Common Stock 10/04/2016 C 172,967 A 2,780,867 I By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P. ( 3 ) Common Stock 10/04/2016 P 8,000 A $ 12 2,788,867 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series A Preferred Stock ( 1 ) ( 2 ) 10/04/2016 C 2,941,176 ( 4 ) ( 4 ) Common Stock 1,516,070 ( 1 ) ( 2 ) $ 0 ( 1 ) ( 2 ) 0 I By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P. ( 3 ) Series A-1 Preferred Stock ( 1 ) ( 2 ) 10/04/2016 C 1,883,763 ( 4 ) ( 4 ) Common Stock 971,012 ( 1 ) ( 2 ) $ 0 ( 1 ) ( 2 ) 0 I By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P. ( 3 ) Series B Preferred Stock ( 1 ) ( 2 ) 10/04/2016 C 335,557 ( 4 ) ( 4 ) Common Stock 172,967 ( 1 ) ( 2 ) $ 0 ( 1 ) ( 2 ) 0 I By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P. ( 3 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other GAUSLING MICHAEL J 205 WEBSTER STREET BETHLEHEM, PA18015 X Signatures /s/ Michael Gausling 10/04/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2) ( 2 )and (h) 83,160 shares of common stock held by Originate #1Q. ( 3 )The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. ( 4 )All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.